Senti Biosciences stockholders elect three Class III directors and ratify KPMG as auditor

Senti Biosciences, Inc.

Brenda Cooperstone, James Collins, and Feng Hsiung elected as Class III directors to serve until 2028 annual meeting.
Each director received over 17.3M votes for; broker non-votes ~1.2M per nominee.
KPMG LLP ratified as independent auditor for FY2025 with 18,617,895 votes for, 13,519 against, 2,887 abstain.
~71% of outstanding shares (18.6M of 26.1M) represented at the virtual annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.